AI assistant
Cryoport, Inc. — Director's Dealing 2023
Mar 14, 2023
32876_dirs_2023-03-13_1dd093c3-c5ce-4546-8716-6a9c77a421f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2023-03-09
Reporting Person: SHELTON JERRELL (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-09 | Common Stock | M | 8250 | — | Acquired | 439386 | Direct |
| 2023-03-13 | Common Stock | S | 3798 | $20.14 | Disposed | 435588 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-09 | Restricted Stock Rights | $ | M | 8250 | Disposed | Common Stock (8250) | Direct |
Footnotes
F1: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
F2: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights
F3: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023.